Adult Solid Neoplasm

cancer

Identifier: CI-CAN-00000062
Entity page: /cancer/adult-solid-neoplasm ↗
Edges: 1,327

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Adult Solid Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 163show all (up to 200)
→ investigated in trials for	Paclitaxelsmall molecule 51 trials (4 active) · roll-up of the cancer and its descendants	—	—	Adult Solid Neoplasm	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule

Adult Solid Neoplasm studied in …STUDIED_INderived10 of 1,164show all (up to 200)
→ studied in	NCT06098651Phase 1 · completed A Study of DCR-STAT3 in Adults With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06088004Phase 1/Phase 2 · recruiting Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04221204Phase 1 · completed A Monotherapy in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active)	—	—	Adult Solid Neoplasm	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains